费布里病与膜性病的共存:一个病例报告
1Department of Nephrology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.
Iranian journal of kidney diseases
|October 18, 2024
概括
这个案例研究突出了一个患有法布里病和膜性病的女性,展示了罕见的共发生. 在这种复杂的遗传性病中,早期诊断和治疗对于管理蛋白尿症至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 费布里病 (FD) 是一种罕见的X链 lysosomal储存障碍.
- FD可以与各种淋巴结膜病变共存,使诊断和管理复杂化.
- 膜性病 (MN) 是成年人性综合征的常见原因.
研究的目的:
- 报告一个独特的Fabry病病例与II阶段膜性病共存在一个32岁的女性.
- 强调FD和MN共存的诊断挑战和治疗策略.
- 为了说明基因测试和酶活性测试在诊断FD中的重要性.
主要方法:
- 临床表现分析包括蛋白尿,正常功能和低.
- 用光和电子显微镜进行脏活检,以识别亚皮质沉积物,底层膜加厚和骨髓体.
- 生物化学测试的α-galactosidase A活动和遗传突变分析 (c.335G > Ap.Arg112His).
主要成果:
- 患者呈现蛋白尿和缺水症,后来诊断出同时存在的FD和MN.
- 脏活检证实了MN的特征,并建议FD.
- 通过较低的α-galactosidase A活性和一种致病性异构酶突变确认了FD诊断.
- 拉米普利尔的初始治疗使蛋白尿正常化,后来尽管治疗Allisartan isoproxil,但蛋白尿再次复发.
结论:
- 费布里病和膜性病的共存是罕见的,并带来了诊断挑战.
- 包括遗传检测在内的全面诊断工作对于识别患有淋巴结核病的患者的FD至关重要.
- 在共存的FD和MN中,蛋白尿的管理需要量身定制的治疗方法.
- 需要进一步的研究来优化这种复杂的患者群体的治疗策略.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
1
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
1
Nephrotic Syndrome I : Introduction
1
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


